Organon & Co.
(OGN)
Add Watchlist
19.61 USD +0.50
Closed: 03 May, 3:55 pm
Symbol OGN
Market Cap 5B
Price 19.61
Open 20.00
52-wk High 24.08
50 Day Avg 18.16
Earnings Announcement 2024-05-02
Website https://www.organon.com
Name Organon & Co.
Shares Outstanding 255,638,000
Change % 0.5641%
Low 19.41
52-wk Low 10.84
200 Day Avg 17.15
Last Dividend 1.12
Exchange NYSE
Volume 3,199,431
Previous Close 19.50
High 20.30
EPS 3.99
PE 4.91
Avg Volume 2,380,020
CUSIP 68622V106
Organon & Co. Outlook
Description Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.
Currency USD
ISIN US68622V1061
Industry Drug Manufacturers - General
Changes 0.11
CUSIP 68622V106
Range 10.84 - 24.08
Beta 0.79
CIK 0001821825

Organon & Co. News

02-May-2024 1:01 PM

What Makes Organon (OGN) a New Buy Stock

Organon (OGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

02-May-2024 9:55 AM

Organon (OGN) Tops Q1 Earnings and Revenue Estimates

Organon (OGN) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $1.08 per share a year ago.

01-May-2024 1:26 PM

7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024

Sleeper stocks to buy – based on Nasdaq.com's glossary – represent securities that offer significant price appreciation potential once its fundamentals have been recognized. That could cover a lot of enterprises so I decided to narrow down the list.

01-May-2024 12:05 PM

Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?

Organon's (OGN) first-quarter results are likely to reflect growth in its biosimilars and established brand franchises with lighter fertility product sales amid foreign exchange headwinds.

01-May-2024 10:47 AM

3 Healthcare Stocks With the Potential to Triple Your Investment by 2026

Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks.

29-Apr-2024 10:22 AM

Stay Ahead of the Game With Organon (OGN) Q1 Earnings: Wall Street's Insights on Key Metrics

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Organon (OGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

25-Apr-2024 11:08 AM

Earnings Preview: Organon (OGN) Q1 Earnings Expected to Decline

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

24-Apr-2024 7:05 PM

Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing

Organon (OGN) reachead $18.71 at the closing of the latest trading day, reflecting a +1.03% change compared to its last close.

22-Apr-2024 7:21 PM

Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know

In the closing of the recent trading day, Organon (OGN) stood at $18, denoting a +1.01% change from the preceding trading day.

15-Apr-2024 7:21 PM

Organon (OGN) Advances While Market Declines: Some Information for Investors

In the latest trading session, Organon (OGN) closed at $17.71, marking a +1.49% move from the previous day.

12-Apr-2024 9:11 AM

Play Safe! S&P 500 is Teasingly Close to its 50 DMA: 3 Picks

With the S&P 500 trading close to its 50-day moving average, it's wise for investors to place bets on safe stocks such as Iron Mountain (IRM), Organon (OGN), and International Business Machines (IBM).